Here is a good post by @gingerclam today. Worth noting the speaker Hassan De Silva is probably one of the best Biotech analysts out there.
https://hotcopper.com.au/posts/74761760/single
What appeals to me, is our Fast Track designation for treating Bile Duct Cancer! It’s started dosing last week. With only 10 pax needed , and probably at OBD, we might have our very first FDA marketing approval in view.
Considering the amount of BEAUTIFUL DATA IMU has collected particularly in the gastric space , this 10 Pax trial might just get us our first approval.
This is a rare disease. An orphan disease .
If this works out IMU will be off to the races here. And will know that by years end.
It’s quite possible just the release of the Bile Duct Trial results might set this off. Of course the release of specific news about further expansion trials will addd add fuel to this fire! Let’s hope we get an announcement that says “FDA approves expansion trial for ####### cancer”
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-14667
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
-0.002(3.39%) |
Mkt cap ! $418.9M |
Open | High | Low | Value | Volume |
6.0¢ | 6.2¢ | 5.6¢ | $1.863M | 31.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 60000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 214965 | 0.057 |
14 | 1550875 | 0.056 |
26 | 4138021 | 0.055 |
9 | 1730287 | 0.054 |
4 | 131036 | 0.053 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 60000 | 1 |
0.059 | 708216 | 4 |
0.060 | 1196314 | 8 |
0.061 | 471000 | 3 |
0.062 | 236412 | 6 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online